Zeng Yu, Xiang Qian, Yin Yiyuan, Zeng Zhaojin, Shen Ziyuan, Wei Senhao, Yu Yao, Ying Deng, Cong Zhukai
Department of Anaesthesiology, Peking University Third Hospital, 49 North Garden Road, Haidian District, Beijing, 100191, China.
Department of Critical Care Medicine, Peking University Third Hospital, 49 North Garden Road, Haidian District, Beijing, 100191, China.
BMC Nephrol. 2025 Aug 29;26(1):498. doi: 10.1186/s12882-025-04421-8.
BACKGROUND: Norepinephrine (NE) has been reported to not only regulate cardiovascular activity but also influence inflammatory responses. But its role in sepsis-associated acute kidney injury (SA-AKI) has yet to be elucidated. METHODS: SA-AKI mouse model was induced by intraperitoneally instillation of lipopolysaccharide. After treatment with NE, haemodynamic changes, kidney pathological injury, kidney funcion, systemic and kidney inflammatory responses, were evaluated. Cytokine levels and nuclear factor κB (NF-κB), MAPKs and Akt signalling pathways of macrophages were measured in vitro. Intercellular tight junction and cell viability were detected to evaluate the effect of macrophage inflammatory response on renal tubular epithelium. RESULTS: NE enhanced cardiovascular haemodynamics, alleviated kidney histopathological injury and inflammatory cell infiltration, lowered the levels of kidney cytokines, NGAL, and KIM-1, as well as serum cytokines in SA-AKI mice. In vitro experiments indicated that NE suppressed the secretion of TNF-α, IL-6, and enhanced IL-10 secretion via a mechanism that involves inhibiting NF-κB rather than MAPKs or Akt activation of macrophage, and further alleviated the damage of renal tubule epithelium. CONCLUSION: NE ameliorated SA-AKI via a mechanism that involves inhibiting NF-κB activation to suppress excessive inflammatory responses of macrophages, and improve the injury of renal tubule epithelium, on its basis of improvement of hemodynamic changes in septic mice. CLINICAL TRIAL NUMBER: Not applicable.
背景:据报道,去甲肾上腺素(NE)不仅可调节心血管活动,还能影响炎症反应。但其在脓毒症相关性急性肾损伤(SA-AKI)中的作用尚待阐明。 方法:通过腹腔注射脂多糖诱导建立SA-AKI小鼠模型。给予NE治疗后,评估血流动力学变化、肾脏病理损伤、肾功能、全身及肾脏炎症反应。体外检测巨噬细胞的细胞因子水平以及核因子κB(NF-κB)、丝裂原活化蛋白激酶(MAPKs)和蛋白激酶B(Akt)信号通路。检测细胞间紧密连接和细胞活力,以评估巨噬细胞炎症反应对肾小管上皮的影响。 结果:NE增强了心血管血流动力学,减轻了肾脏组织病理学损伤和炎症细胞浸润,降低了SA-AKI小鼠的肾脏细胞因子、中性粒细胞明胶酶相关脂质运载蛋白(NGAL)和肾损伤分子-1(KIM-1)水平以及血清细胞因子水平。体外实验表明,NE通过抑制NF-κB而非巨噬细胞的MAPKs或Akt激活的机制,抑制肿瘤坏死因子-α(TNF-α)、白细胞介素-6(IL-6)的分泌,并增强白细胞介素-10(IL-10)的分泌,进而减轻肾小管上皮损伤。 结论:NE通过抑制NF-κB激活以抑制巨噬细胞过度炎症反应、改善肾小管上皮损伤的机制,改善了SA-AKI,其作用基于改善脓毒症小鼠的血流动力学变化。 临床试验编号:不适用。
Int Immunopharmacol. 2025-8-18
Intensive Care Med. 2024-4
J Intensive Med. 2023-9-9